United States Pharmaceuticals

Patheon BV (PTHN)

Track

Track

Ticker: PTHN Exchange: NYQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
LEVY PAUL S Non-Executive Director
Transaction date
Purchase
Price
459.29
Quantity 78,660 +17.9%
Value US$1,123,626
LEVY PAUL S Non-Executive Director
Transaction date
Purchase
Price
321.56
Quantity 53,096 +39.0%
Value US$4,241,787
LEVY PAUL S Non-Executive Director
Transaction date
Purchase
Price
36.92
Quantity 48,255 -45.1%
Value US$1,811,851
LEVY PAUL S Non-Executive Director
Transaction date
Purchase
Price
29.65
Quantity 5,000 +11.9%
Value US$148,250
LEVY PAUL S Non-Executive Director
Transaction date
Purchase
Price
29.65
Quantity 5,000 +13.5%
Value US$148,250
LEVY PAUL S Non-Executive Director
Transaction date
Purchase
Price
28.01
Quantity 37,000 +inf%
Value US$1,036,370
JLL Associates G.P. V (Patheon), Ltd. Large shareholder
Transaction date
Purchase
Price
19.85
Quantity 40,287 +inf%
Value US$799,496
Koninklijke DSM N.V. Large shareholder
Transaction date
Sale
Price
19.85
Quantity 4,761,905 -8.9%
Value US$94,500,005
McMullen Jeffrey P Non-Executive Director
Transaction date
Purchase
Price
19.85
Quantity 10,000 +84.0%
Value US$198,450
Daley Pamela Non-Executive Director
Transaction date
Purchase
Price
19.85
Quantity 48,800 +409.9%
Value US$968,436
JLL Associates G.P. V (Patheon), Ltd. Large shareholder
Transaction date
Purchase
Price
19.85
Quantity 775,443 +3.3%
Value US$15,388,666
Eykerman Philip Non-Executive Director
Transaction date
Purchase
Price
25.00
Quantity 28,000 +inf%
Value US$700,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-10-03 2016-09-30 B Purchase LEVY PAUL S Non-Executive Director
78,660 +17.9%
459.29
US$1,123,626 		78,660 +17.9% 459.29 US$1,123,626
2016-10-03 2016-09-29 B Purchase LEVY PAUL S Non-Executive Director
53,096 +39.0%
321.56
US$4,241,787 		53,096 +39.0% 321.56 US$4,241,787
2016-09-28 2016-09-28 B Purchase LEVY PAUL S Non-Executive Director
48,255 -45.1%
36.92
US$1,811,851 		48,255 -45.1% 36.92 US$1,811,851
2016-09-28 2016-09-27 B Purchase LEVY PAUL S Non-Executive Director
5,000 +11.9%
29.65
US$148,250 		5,000 +11.9% 29.65 US$148,250
2016-09-28 2016-09-26 B Purchase LEVY PAUL S Non-Executive Director
5,000 +13.5%
29.65
US$148,250 		5,000 +13.5% 29.65 US$148,250
2016-09-14 2016-09-12 B Purchase LEVY PAUL S Non-Executive Director
37,000 +inf%
28.01
US$1,036,370 		37,000 +inf% 28.01 US$1,036,370
2016-07-28 2016-07-26 B Purchase JLL Associates G.P. V (Patheon), Ltd. Large shareholder
40,287 +inf%
19.85
US$799,496 		40,287 +inf% 19.85 US$799,496
2016-07-28 2016-07-26 S Sale Koninklijke DSM N.V. Large shareholder
4,761,905 -8.9%
19.85
US$94,500,005 		4,761,905 -8.9% 19.85 US$94,500,005
2016-07-28 2016-07-26 B Purchase McMullen Jeffrey P Non-Executive Director
10,000 +84.0%
19.85
US$198,450 		10,000 +84.0% 19.85 US$198,450
2016-07-28 2016-07-26 B Purchase Daley Pamela Non-Executive Director
48,800 +409.9%
19.85
US$968,436 		48,800 +409.9% 19.85 US$968,436
2016-07-28 2016-07-26 B Purchase JLL Associates G.P. V (Patheon), Ltd. Large shareholder
775,443 +3.3%
19.85
US$15,388,666 		775,443 +3.3% 19.85 US$15,388,666
2016-07-25 2016-07-21 B Purchase Eykerman Philip Non-Executive Director
28,000 +inf%
25.00
US$700,000 		28,000 +inf% 25.00 US$700,000
Explore more

More insider trading research around Patheon BV

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America